Cargando…

Statins Do Not Reduce Atrial Fibrillation After Cardiac Valvular Surgery: A Single Centre Observational Study

INTRODUCTION: Statins may theoretically reduce postoperative atrial fibrillation (AF) in patients after cardiac valvular surgery due to preservation of endothelial function and anti-ischaemic, anti-inflammatory and anti-remodelling effects. METHODS: Two hundred seventy-two patients who underwent car...

Descripción completa

Detalles Bibliográficos
Autores principales:	Folkeringa, R. J., Tieleman, R. G., Maessen, J. G., Prins, M. H., Nieuwlaat, R., Crijns, H. J. G. M.
Formato:	Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021194/ https://www.ncbi.nlm.nih.gov/pubmed/21350586 http://dx.doi.org/10.1007/s12471-010-0055-3

Ejemplares similares

Economic Evaluation of Apixaban for the Prevention of Stroke in Non-Valvular Atrial Fibrillation in the Netherlands
por: Stevanović, Jelena, et al.
Publicado: (2014)

Rate control drugs differ in the prevention of progression of atrial fibrillation
por: Koldenhof, Tim, et al.
Publicado: (2021)

Rate control with calcium channel blockers versus betablockers in patients with paroxysmal and persistent atrial fibrillation - data from the AFFIRM trial
por: Koldenhof, T, et al.
Publicado: (2023)

Feasibility of TEE-guided stroke risk assessment in atrial fibrillation—background, aims, design and baseline data of the TIARA pilot study
por: Dinh, T., et al.
Publicado: (2011)

Metabolomic and Proteomic Analyses of Persistent Valvular Atrial Fibrillation and Non-Valvular Atrial Fibrillation
por: Hu, Bo, et al.
Publicado: (2021)

The symbiosis of contact force catheter use for hybrid ablation for atrial fibrillation
por: Kumar, N., et al.
Publicado: (2015)

Left Atrial Appendage Management with the Watchman Device during Hybrid Ablation of Atrial Fibrillation
por: Vroomen, Mindy, et al.
Publicado: (2019)

Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
por: Samaras, Athanasios, et al.
Publicado: (2021)

Adenosine administration during hybrid atrial fibrillation ablation to test dormant pulmonary vein conduction
por: Vroomen, Mindy, et al.
Publicado: (2017)

Newer Anticoagulants for Non-Valvular Atrial Fibrillation
por: Harburger, Joseph M., et al.
Publicado: (2012)

Clinical characteristics and 12-month outcomes of patients with valvular and non-valvular atrial fibrillation in Kenya
por: Temu, Tecla M., et al.
Publicado: (2017)

Idiopathic atrial fibrillation patients rapidly outgrow their low thromboembolic risk: a 10-year follow-up study
por: Weijs, B., et al.
Publicado: (2019)

Non-valvular atrial fibrillation: impact of apixaban on patient outcomes
por: Ioannou, Adam, et al.
Publicado: (2017)

Novel oral Anticoagulants in Non-Valvular Atrial Fibrillation
por: da Silva, Rose M.F.L.
Publicado: (2014)

Epicardial and Endocardial Validation of Conduction Block After Thoracoscopic Epicardial Ablation of Atrial Fibrillation
por: Vroomen, Mindy, et al.
Publicado: (2020)

Causes of death of patients with non-valvular atrial fibrillation in Asians
por: Krittayaphong, Rungroj, et al.
Publicado: (2023)

Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
por: Jacobs, M. S., et al.
Publicado: (2018)

Optimal long-term antithrombotic management of atrial fibrillation: life cycle management
por: Pisters, R., et al.
Publicado: (2018)

Time of onset of atrial fibrillation and atrial fibrillation progression data from the RACE V study
por: van de Lande, Martijn E, et al.
Publicado: (2023)

Clinical and electrophysiological predictors of device-detected new-onset atrial fibrillation during 3 years after cardiac surgery
por: Bidar, Elham, et al.
Publicado: (2021)

Effects of a simple cardiac rehabilitation program on improvement of self-reported physical activity in atrial fibrillation – Data from the RACE 3 study
por: Nguyen, Bao Oanh, et al.
Publicado: (2020)

Stroke Prevention in Atrial Fibrillation and Valvular Heart Disease
por: Ahmad, Saad, et al.
Publicado: (2016)

The relation between the atrial blood supply and the complexity of acute atrial fibrillation()
por: Dudink, Elton A.M.P., et al.
Publicado: (2021)

Relationship between valvular structure and biochemical indices of non-valvular atrial fibrillation and senile degenerative valvular heart disease
por: Chen, Jian-Qin, et al.
Publicado: (2023)

Statin use improves the outcomes in patients with atrial fibrillation: A population-based study
por: Huang, J, et al.
Publicado: (2023)

Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban
por: Breithardt, Günter, et al.
Publicado: (2016)

Paradigm shifts in pathophysiology and management of atrial fibrillation—a tale of the RACE trials in the Netherlands
por: Crijns, H. J. G. M., et al.
Publicado: (2020)

Anticoagulant Prescribing for Non‐Valvular Atrial Fibrillation in the Veterans Health Administration
por: Rose, Adam J., et al.
Publicado: (2019)

Suboptimal oral anticoagulant treatment among Chinese non-valvular atrial fibrillation patients: the Nanchang Atrial Fibrillation Project
por: Xiong, Qinmei, et al.
Publicado: (2016)

Association of inflammation indices with left atrial thrombus in patients with valvular atrial fibrillation
por: Zhou, You, et al.
Publicado: (2023)

Persistent or permanent atrial fibrillation is associated with severe cardioembolic stroke in patients with non-valvular atrial fibrillation
por: Hagii, Joji, et al.
Publicado: (2021)

Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation
por: Nguyen, Bao-Oanh, et al.
Publicado: (2023)

Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non‐valvular atrial fibrillation (cognitive decline and dementia in patients with non‐valvular atrial fibrillation [CAF] trial)
por: Bunch, Thomas Jared, et al.
Publicado: (2022)

Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study
por: Alings, M., et al.
Publicado: (2013)

Prevalence of Valvular and Non-valvular Atrial Fibrillation and the Application of Antithrombotic Treatment in a Tertiary Care Hospital
por: Dhungana, Sahadeb Prasad, et al.
Publicado: (2020)

Postoperative atrial fibrillation and atrial epicardial fat: Is there a link?
por: van der Heijden, Claudia A.J., et al.
Publicado: (2022)

Newly discovered atrial fibrillation: who(se) care(s)?
por: Crijns, Harry J G M, et al.
Publicado: (2020)

Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation
por: Tieleman, R.G., et al.
Publicado: (2014)

Brady- and tachyarrhythmias in paroxysmal atrial fibrillation: results from long-term continuous electrocardiographic monitoring in RACE V
por: Park Frausing, M H J, et al.
Publicado: (2023)

Opportunities and challenges of large-scale screening for atrial fibrillation
por: Zink, Matthias Daniel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_etbnup6q7cd4h12dal4rqd7hqa